0001179110-18-001861.txt : 20180208 0001179110-18-001861.hdr.sgml : 20180208 20180208201435 ACCESSION NUMBER: 0001179110-18-001861 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180206 FILED AS OF DATE: 20180208 DATE AS OF CHANGE: 20180208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vetticaden Santosh CENTRAL INDEX KEY: 0001386932 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13111 FILM NUMBER: 18587291 MAIL ADDRESS: STREET 1: C/O ADVENTRX PHARMACEUTICALS, INC. STREET 2: 12390 EL CAMINO REAL, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEPOMED INC CENTRAL INDEX KEY: 0001005201 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943229046 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7999 GATEWAY BLVD. STREET 2: SUITE 300 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-744-8000 MAIL ADDRESS: STREET 1: 7999 GATEWAY BLVD. STREET 2: SUITE 300 CITY: NEWARK STATE: CA ZIP: 94560 4 1 edgar.xml FORM 4 - X0306 4 2018-02-06 0 0001005201 DEPOMED INC DEPO 0001386932 Vetticaden Santosh C/O DEPOMED INC. 7999 GATEWAY BOULEVARD, SUITE 300 NEWARK CA 94560 0 1 0 0 SVP, Chief Medical Officer *** Restricted Stock Units 2018-02-06 4 A 0 36800 0 A Common Stock 36800 36800 D Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. These restricted stock units are scheduled to vest 33.33% on February 6, 2019, 33.33% on February 6, 2020 and 33.33% on February 6, 2021, assuming continued employment through the applicable vesting date. *** Santosh's title is Senior Vice President, Chief Medical and Scientific Officer. /s/ Santosh J. Vetticaden 2018-02-08